Healthcare sector contests USTR claim on excess capacity

After the US launched Section 301 investigations into structural excess capacity across several countries including India, targeting manufacturing sectors, domestic pharma and medical device sectors have submitted their positions amid such potential concerns.

Raccontata datimesofindia.indiatimes.com